Searchable abstracts of presentations at key conferences in endocrinology

ea0063p693 | Pituitary and Neuroendocrinology 2 | ECE2019

Ectopic neurohypophysis: an unusual cause of growth hormone deficiency

Zargni Asma , Jaidane Amel , El Arbi Kawthar , Zouaoui Chadia , Ouertani Haroun

Introduction: The ectopic posterior pituitary is a rare condition which is characterized by the ectopic location of posterior lobe of pituitary, pituitary stalk abnormalities, and associated clinical manifestations of anterior lobe related growth hormone dysfunction or less commonly multiple anterior pituitary dysfunctions. We describe the case of a young female who presented with short stature and was found to have ectopic posterior pituitary.Case prese...

ea0081p554 | Calcium and Bone | ECE2022

Effect of glucocorticoid replacement therapy on bone mineral density in addison disease

Ben Salah Dhoha , Boujelben Khouloud , El Arbi Kawthar , Kacem Akid Faten Haj , Soomauroo Siddiqa , Mnif Mouna , Charfi Nadia , Fatma Mnif , Majdoub Nabila Rekik , Elleuch Mouna , Abid Mohamed

Introduction: Addison disease is associated with high risk of fractures and low bone mineral density. Causes are complex, including supraphysiologic glucocorticoid replacement therapy and concomitant autoimmune disorders. The aim of our study is to assess the influence of glucorticoid replacement therapy on bone mineral density in patients with Addison disease.Patients and methods: Descriptive and analytical cross- sectional study including 50 patients w...

ea0081ep391 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Cardiovascular risk in diabetic patients with chronic kidney disease: One more turn of the screw

Missaoui Abdelmouhaymen , Fatma Mnif , Zargni Asma , El Arbi Kawthar , Ben Salah Dhoha , Elleuch Mouna , Haj Kacem Akid Faten , Charfi Nadia , Mnif Mouna , Rekik Majdoub Nabila , Abid Mohamed

Background: Poor glycemic control in patients with diabetes mellitus(DM) is a well-documented responsible factor for microvascular complications, especially eye and kidney damage. The onset of chronic kidney disease(CKD) marks a serious turning point in the clinical history of DM in terms of cardiovascular prognosis. Our study aims to assess the cardiovascular risk(CVR) in diabetic patients with CKD.Method: We conducted a retrospective descriptive study ...

ea0081ep398 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Berberis vulgaris: perspectives in the treatment of non alcoholic fatty liver disease

Fatma Mnif , Zargni Asma , El Arbi Kawthar , Ben Salah Dhoha , Bousetta Salma , Elleuch Mouna , Charfi Nadia , Mnif Mouna , Rekik Majdoub Nabila , Haj Kacem Akid Faten , Abid Mohamed

Introduction: Berberis vulgaris is a plant, of the family Berberidaceae. Berberine is the main active compound of the barberry. It is an iso quinoline alkaloid of intense yellow color. Berberis vulgaris is used in several medical purposes, including liver protection, anti-oxidant, antimicrobial agent. It also seems to reduce the level of cholesterol in the blood and triglycerides. Our study aims to investigate the effect of the dietary supplement "Berberis Vulgaris" ma...

ea0081ep407 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Diabetes and pancreatic cancer: what link?

Haj Kacem Akid Faten , Zargni Asma , El Arbi Kawthar , Ben Salah Dhoha , Fatma Mnif , Charfi Nadia , Mnif Mouna , Rekik Majdoub Nabila , Elleuch Mouna , Abid Mohamed

Introduction: Pancreatic cancer is one of the digestive system cancers whose prognosis has not been improved, both in terms of early diagnosis and prognosis, despite the progress in clinical, radiological and biological investigation. A significant number of patients present at the time of diagnosis of this cancer, or just before, a relatively recent onset diabetes. The link between diabetes and pancreatic cancer is established, but it is sometimes difficult to distinguish whe...

ea0081ep500 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Comparative study of epidemiological, clinical and paraclinical characteristics between a group of complicated obese versus uncomplicated obese: about 400 cases

Mnif Fatma , Souissi Mariem , Ben Salah Dhoha , Boujelben Khouloud , El Arbi Kawthar , Mnif Mouna , Rekik Majdoub Nabila , Elleuch Mouna , Charfi Nadia , Abid Mohamed

Introduction: Obesity, through its complications, influences the functional and vital prognosis. The search for these complications constitutes a major axis of the management of the obese patient, independently of the weight loss. The objective of this work is to focus on the different complications of obesity and to identify, through a comparative study between two groups of obese patients, complicated versus uncomplicated, the different predictive factors of the occurrence o...

ea0063p848 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Synchronous tumours: Neuroendocrine Tumours and Breast cancer

Mnif Fatma , El Arbi Kawthar , Hadj Kacem Faten , Zargni Asma , Elleuch Mouna , Ben Salah Douha , Charfi Nedia , Mnif Mouna , Rekik Nabila , Abid Mohamed

Introduction:: The association of breast cancer and neuroendocrine tumours, in particular pheochromocytoma, is rarely described in the literature. We report a case in a particular context.Observation: This is a 53-year-old patient treated with 6 courses of chemotherapy for T2N3cM0 infiltrating breast carcinoma. She was admitted to our endocrinology department for exploration of a left adrenal incidentaloma, objectified in the extension assessment, measur...

ea0063p1175 | Thyroid 3 | ECE2019

Familial autoimmune polyglandular syndrome: a case report

Ben Salah Dhouha , Saafi Wiem , Kacem Feten Hadj , Mnif Fatma , El Arbi Kawthar , Elleuch Mouna , Charfi Nadia , Mnif Mouna , Rekik Nabila , Abid Mohamed

Introduction: Autoimmune polyglandular syndrome (APS) is an autoimmune disorder that affects many endocrine glands. Until now four categories of APS are identified: APS-I includes at least two out of: mucocutaneous candidiasis, hypoparathyroidism and adrenocortical failure. APS-II, the most frequent, comprises of AddisonÂ’s disease, autoimmune thyroid disease and/or type 1 diabetes. APS-III is defined by the presence of autoimmune thyroid disease and other autoimmune disor...

ea0073ep62 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Characteristics of non-alcoholic steatohepatitis in patients with type 1 diabetes: a study of 8 cases

Ben Salah Dhoha , Mohamed Abdellahi Mohamed Ahmed , Elleuch Mouna , El Arbi Kawthar , Mnif Mouna , Rekik Majdoub Nabila , Charfi Nadia , Kacem Faten Hadj , Mohamed Abid

IntroductionNon alcoholic steato-hepatitis (NASH) is the most common chronic liver disease in developed countries rare in type 1 diabetes it is associated with an increased risk of complications in patients with type 1 diabetes mellitus (T1DM). The aim of this study is to clarify the characteristics of NASH in patients with T1DM.Materials and methodswe conducted a retrospective descriptive study in non-alcoho...

ea0073ep199 | Thyroid | ECE2021

Unmasked Graves’ disease following tamoxifen withdrawal

El ArbI Kawthar , Safi Wajdi , Boujelben Khouloud , Mohamed Abdellahi Mohamed Ahmed , Mohamed Elmoctar Sidina , Mejdoub Nabila , Mnif Mouna , Kacem Faten Hadj , Mohamed Abid

IntroductionThe synthetic anti-oestrogen tamoxifen is the endocrine treatment modality most commonly used for therapy of hormone sensitive breastcancer. The influence of tamoxifen on thyroid function has not been fully elucidated.ObservationA 46-year-old female patient who presented a GravesÂ’ disease diagnosed 10 years ago. She had a moderate vascular goiter and no ocular signs. She presented firstly a s...